(269 days)
Yes
The device description states, "The cloud-based VitalRhythm software application supports the analysis of ECG data and RR-interval using a proprietary algorithm developed using deep learning techniques." The "Mentions AI, DNN, or ML" section also confirms the use of "deep learning techniques" and "machine-learning techniques."
No
Explanation: The device is a diagnostic software that analyzes cardiac arrhythmias from ECG data but does not provide any therapy or treatment.
Yes
The device analyzes ECG and RR-interval data to detect and report cardiac arrhythmias, which are then reviewed by healthcare professionals for clinical decision-making. Although it is not the sole means of diagnosis and is advisory, its primary function is to provide analytical results for diagnostic purposes.
No
The device is described as a "cloud-based software application for continuous and automatic analysis of cardiac arrhythmias," but its operation specifically requires and integrates with the "VitalPatch biosensor" for data input (ECG and RR-interval data measurement) and the "VistaCenter web application" for display, making it part of a broader "Vista Solution" platform that includes hardware components. While the software itself might be "software-only," its medical device functionality (intended use) is inextricably linked to specific hardware not developed by the submitter of this 510(k). The device description explicitly states: "VitalRhythm accepts ECG and RR-interval data transmitted from the VitalPatch," and states "The features, operating procedures, and mitigations in place for the compatible devices ensure continuous data collection and transmission to support the VitalRhythm application for the intended use." Therefore, the medical device as a whole, for its intended use, is not software-only.
No.
The device analyzes ECG data and RR-intervals from a biosensor, which is physiological data. It does not analyze specimens derived from the human body.
No
The clearance letter does not explicitly state that the FDA has reviewed and approved or cleared a Predetermined Change Control Plan (PCCP) for this specific device.
Intended Use / Indications for Use
VitalRhythm is a cloud-based software application for continuous and automatic analysis of cardiac arrhythmias. VitalRhythm is compatible with the "Vista Solution" platform, which includes the VitalPatch biosensor and VistaCenter web application. VitalRhythm is intended to be used for outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making. VitalRhythm provides analysis of cardiac arrhythmias using ECG data and RR-interval from the VitalPatch in patients who are 18 years of age or older. Results of the VitalRhythm are displayed within the VistaCenter web application to be reviewed and confirmed by qualified healthcare professionals and/or cardiac technicians. VitalRhythm is not intended for use in life-supporting or sustaining systems or for critical care monitoring. The arrhythmia analysis results are not intended to be the sole means of diagnosis and are offered on an advisory basis only, in conjunction with the physician's knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information.
Product codes
DQK, DPS, QYX
Device Description
VitalRhythm is a cloud-based, arrhythmia detection software application that is compatible and intended to be used with the VitalConnect "Vista Solution" platform. The Vista Solution Platform consists of the VitalPatch biosensor, a phone (VistaPhone) or tablet (VistaTablet) relay device preloaded with the VistaPoint software application, VC Cloud and the cloud-based VistaCenter user interface.
VitalRhythm is intended to be used for outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making.
VitalRhythm analyzes ECG data and RR-interval from the VitalPatch biosensor for reporting of cardiac arrhythmias to be reviewed and adjudicated by qualified healthcare professionals and/or cardiac technicians.
The cloud-based VitalRhythm software application supports the analysis of ECG data and RR-interval using a proprietary algorithm developed using deep learning techniques. The application works in the following way:
-
VitalRhythm accepts ECG and RR-interval data transmitted from the VitalPatch via a secure, cloud-based API (Application Programming Interface)
-
ECG and RR-interval data are analyzed by VitalRhythm using a proprietary algorithm, which detects the following cardiac rhythms:
- Atrial fibrillation/atrial flutter
- AV Block (2nd degree, Type I and II)
- Pause
- Paroxysmal supraventricular tachycardia (PSVT)
- Ventricular tachycardia/run
- Sinus bradycardia
- Sinus tachycardia
- Normal sinus rhythm
- Others (inconclusive)
-
For use with Mobile Cardiac Telemetry (MCT), i.e., outpatient cardiac telemetry: any of the above listed arrhythmias that are detected by the software algorithm are displayed in VistaCenter to be reviewed and analyzed by a qualified cardiac technician in the 24/7 attended Cardiac Monitoring Center, prior to transmitting a notifiable event consistent with the prescribed notification criteria to the prescribing physician during the monitoring period. An event report is generated by VistaCenter as a result of the analysis.
For use with patient monitoring in non-critical healthcare settings: any of the above listed arrhythmias that are detected by the software algorithm are displayed and notified in VistaCenter, in accordance with the notification criteria, during the monitoring period to be reviewed by the prescribing healthcare professional for non-urgent clinical decision-making.
The features, operating procedures, and mitigations in place for the compatible devices ensure continuous data collection and transmission to support the VitalRhythm application for the intended use. Further information is provided in the VitalRhythm Instructions for Use document.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
The automated proprietary algorithm developed using deep-learning techniques, which measures and analyzes ECG data to provide certified cardiac technicians and qualified healthcare professionals the ability to review and confirm the analytic result
Input Imaging Modality
ECG data and RR-interval
Anatomical Site
Not Found
Indicated Patient Age Range
18 years of age or older
Intended User / Care Setting
Qualified healthcare professionals and/or cardiac technicians / outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings
Description of the training set, sample size, data source, and annotation protocol
The training database was from 354 US clinical sites, and consists of 23,587 patients and 81,391 datasets.
Description of the test set, sample size, data source, and annotation protocol
The independent test database contains VitalPatch data from 3,309 patients (18 years of age or older) across 7 US testing sites and consists of 7,553 datasets with a total of 22,034 annotated arrhythmia episodes indicating a wide sampling of arrhythmias to support a robust generalization of the algorithm. To ensure an unbiased performance assessment, test datasets are sequestered at the clinical site level.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical testing included de-identified ECG and RR-interval data obtained retrospectively from patients prescribed the VitalPatch biosensor across clinical sites in the United States (US). The performance of VitalRhythm, when assessed using the independent test database, in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy is provided in the table. Subgroup analyses performed to evaluate potential heterogeneity (Mann Whitney Wilcoxon test, p ≥ 0.01) in the detection performance of the VitalRhythm algorithm across demographic factors (patients' age, gender, race, ethnicity and body mass index), dataset durations, and testing sites did not result in statistically significant differences. The test results demonstrated that performance of the VitalRhythm algorithm, when assessed on the independent test database, in terms of sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), and accuracy met the acceptance criteria of ≥ 95% for non-sinus rhythms including Atrial fibrillation/ flutter, AV block (2nd degree, Type I and II), Paroxysmal supraventricular tachycardia, Ventricular tachycardia/run, Pause and Others (Inconclusive). Additionally, the test results showed that sinus rhythms including Normal sinus rhythm, Sinus bradycardia and Sinus tachycardia met the acceptance criteria of ≥ 90% with regard to sensitivity, specificity, PPV, NPV, and accuracy.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
| Rhythm | Patient | Dataset | Sensitivity | Specificity | PPV | NPV | Accuracy |
|---|---|---|---|---|---|---|---|
| Atrial fibrillation/ flutter | 421 | 1512 | 99.9 | 99.9 | 99.8 | 99.9 | 99.9 |
| AV block (2nd degree, Type I and II) | 118 | 716 | 98.7 | 100.0 | 99.9 | 99.9 | 99.9 |
| Paroxysmal supraventricular tachycardia | 689 | 1003 | 98.6 | 99.9 | 99.4 | 99.9 | 99.9 |
| Ventricular tachycardia/run | 610 | 737 | 99.3 | 99.9 | 99.4 | 99.9 | 99.9 |
| Pause | 200 | 960 | 99.7 | 100.0 | 99.9 | 100.0 | 100.0 |
| Others (inconclusive) | 1547 | 1923 | 98.9 | 99.9 | 99.2 | 99.9 | 99.9 |
| Sinus | 3009 | 5906 | 99.8 | 99.9 | 99.8 | 99.9 | 99.8 |
| Normal sinus rhythm | 2394 | 4201 | 98.9 | 99.1 | 99.1 | 98.9 | 99.0 |
| Sinus bradycardia | 488 | 1009 | 97.0 | 99.8 | 98.9 | 99.6 | 99.5 |
| Sinus tachycardia | 914 | 1161 | 99.4 | 99.5 | 97.7 | 99.8 | 99.5 |
Predicate Device(s)
Medicalgorithmics S.A. DeepRhythmAI (K241197)
Reference Device(s)
B-Secur Limited HeartKey® Rhythm (K233755), VitalConnect, Inc. Vista Solution (K193343), VitalConnect, Inc. VitalPatch Biosensor (K192757)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1425 Programmable diagnostic computer.
(a)
Identification. A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.(b)
Classification. Class II (performance standards).
FDA 510(k) Clearance Letter - VitalRhythm
Page 1
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
Doc ID # 04017.07.05
April 17, 2025
VitalConnect, Inc.
Gabriel Nallathambi
Director, Algorithm and Data Science
2870 Zanker Road
Suite 100
San Jose, California 95134
Re: K242129
Trade/Device Name: VitalRhythm
Regulation Number: 21 CFR 870.1425
Regulation Name: Programmable Diagnostic Computer
Regulatory Class: Class II
Product Code: DQK, DPS, QYX
Dated: March 18, 2025
Received: March 19, 2025
Dear Gabriel Nallathambi:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Page 2
K242129 - Gabriel Nallathambi Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
Page 3
K242129 - Gabriel Nallathambi Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jennifer W. Shih -S
Jennifer Kozen
Assistant Director
Division of Cardiac Electrophysiology,
Diagnostics, and Monitoring Devices
Office of Cardiovascular Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
Page 4
FORM FDA 3881 (8/23) Page 1 of 1
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.
510(k) Number (if known): K242129
Device Name: VitalRhythm
Indications for Use (Describe)
VitalRhythm is a cloud-based software application for continuous and automatic analysis of cardiac arrhythmias. VitalRhythm is compatible with the "Vista Solution" platform, which includes the VitalPatch biosensor and VistaCenter web application. VitalRhythm is intended to be used for outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making. VitalRhythm provides analysis of cardiac arrhythmias using ECG data and RR-interval from the VitalPatch in patients who are 18 years of age or older. Results of the VitalRhythm are displayed within the VistaCenter web application to be reviewed and confirmed by qualified healthcare professionals and/or cardiac technicians. VitalRhythm is not intended for use in life-supporting or sustaining systems or for critical care monitoring. The arrhythmia analysis results are not intended to be the sole means of diagnosis and are offered on an advisory basis only, in conjunction with the physician's knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information.
Type of Use (Select one or both, as applicable)
☒ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Page 5
VitalConnect, Inc. VitalRhythm Arrhythmia Detection Software
Traditional 510(k): 510(k) Summary
510(k) Notification K242129
I. General Information
Applicant Name and Address:
VitalConnect, Inc.
2870 Zanker Road, Suite 100
San Jose, CA 95134 USA
Phone: 408-963-4600
Applicant Contact Person:
Dr. Gabriel Nallathambi
Director, Algorithm and Data Science
Phone: 408-963-4600
Email: gnallathambi@vitalconnect.com
Date Prepared: April 15, 2025
II. Device Information
Device Trade name: VitalRhythm
Common Name: Programmable Diagnostic Computer
Classification Name:
- Programmable Diagnostic Computer
- Electrocardiograph
- Arrhythmia detector and alarm (including ST-segment measurement and alarm)
Regulation Numbers:
- 21CFR§870.1425
- 21CFR§870.2340
- 21CFR§870.1025
Product Codes:
- DQK - Computer, Diagnostic, Programmable
- DPS – Electrocardiograph
- QYX – Outpatient Cardiac Telemetry
Page 6
III. Legally Marketed Predicate Device
Predicate Device: Medicalgorithmics S.A. DeepRhythmAI (K241197)
Reference Device: B-Secur Limited HeartKey® Rhythm (K233755)
Reference Device: VitalConnect, Inc. Vista Solution (K193343)
Reference Device: VitalConnect, Inc. VitalPatch Biosensor (K192757)
IV. Device Description Summary
VitalRhythm is a cloud-based, arrhythmia detection software application that is compatible and intended to be used with the VitalConnect "Vista Solution" platform. The Vista Solution Platform consists of the VitalPatch biosensor, a phone (VistaPhone) or tablet (VistaTablet) relay device preloaded with the VistaPoint software application, VC Cloud and the cloud-based VistaCenter user interface.
VitalRhythm is intended to be used for outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making.
VitalRhythm analyzes ECG data and RR-interval from the VitalPatch biosensor for reporting of cardiac arrhythmias to be reviewed and adjudicated by qualified healthcare professionals and/or cardiac technicians.
The cloud-based VitalRhythm software application supports the analysis of ECG data and RR-interval using a proprietary algorithm developed using deep learning techniques. The application works in the following way:
-
VitalRhythm accepts ECG and RR-interval data transmitted from the VitalPatch via a secure, cloud-based API (Application Programming Interface)
-
ECG and RR-interval data are analyzed by VitalRhythm using a proprietary algorithm, which detects the following cardiac rhythms:
- Atrial fibrillation/atrial flutter
- AV Block (2nd degree, Type I and II)
- Pause
- Paroxysmal supraventricular tachycardia (PSVT)
- Ventricular tachycardia/run
- Sinus bradycardia
- Sinus tachycardia
- Normal sinus rhythm
- Others (inconclusive)
-
For use with Mobile Cardiac Telemetry (MCT), i.e., outpatient cardiac telemetry: any of the above listed arrhythmias that are detected by the software algorithm are displayed in VistaCenter to be reviewed and analyzed by a qualified cardiac technician in the 24/7
Page 7
attended Cardiac Monitoring Center, prior to transmitting a notifiable event consistent with the prescribed notification criteria to the prescribing physician during the monitoring period. An event report is generated by VistaCenter as a result of the analysis.
For use with patient monitoring in non-critical healthcare settings: any of the above listed arrhythmias that are detected by the software algorithm are displayed and notified in VistaCenter, in accordance with the notification criteria, during the monitoring period to be reviewed by the prescribing healthcare professional for non-urgent clinical decision-making.
The features, operating procedures, and mitigations in place for the compatible devices ensure continuous data collection and transmission to support the VitalRhythm application for the intended use. Further information is provided in the VitalRhythm Instructions for Use document.
V. Intended Use / Indications for Use
VitalRhythm is a cloud-based software application for continuous and automatic analysis of cardiac arrhythmias. VitalRhythm is compatible with the "Vista Solution" platform, which includes the VitalPatch biosensor and VistaCenter web application. VitalRhythm is intended to be used for outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making. VitalRhythm provides analysis of cardiac arrhythmias using ECG data and RR-interval from the VitalPatch in patients who are 18 years of age or older. Results of the VitalRhythm are displayed within the VistaCenter web application to be reviewed and confirmed by qualified healthcare professionals and/or cardiac technicians. VitalRhythm is not intended for use in life-supporting or sustaining systems or for critical care monitoring. The arrhythmia analysis results are not intended to be the sole means of diagnosis and are offered on an advisory basis only, in conjunction with the physician's knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information.
VI. Comparison to Predicate Device
The following table provides a comparison of the intended use and device characteristics of the proposed VitalRhythm device, the DeepRhythmAI predicate device, the HeartKey Rhythm reference device and the compatible VitalConnect reference devices.
| VitalRhythm (VitalConnect, Inc.) K242129 | DeepRhythmAI (Medicalgorithmics S.A.) K241197 | HeartKey® Rhythm (B-Secur Limited) K233755 | Vista Solution (VitalConnect, Inc.) K193343 | VitalPatch Biosensor (VitalConnect, Inc.) K192757 | |
|---|---|---|---|---|---|
| Subject Device | Predicate Device | Reference Device | Reference Device | Reference Device |
Page 8
| Indications for Use | VitalRhythm is a cloud-based software application for continuous and automatic analysis of cardiac arrhythmias. VitalRhythm is compatible with the "Vista Solution" platform, which includes the VitalPatch biosensor and VistaCenter web application. VitalRhythm is intended to be used for outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making. VitalRhythm provides analysis of cardiac arrhythmias using ECG data and RR-interval from the VitalPatch in patients who are 18 years of age or older. Results of the VitalRhythm are displayed within the VistaCenter web application to be reviewed and confirmed by qualified healthcare professionals and/or cardiac technicians. VitalRhythm is not intended for use in | DeepRhythmAI is a cloud-based software for the assessment of cardiac arrhythmias using two lead ECG data in adult patients. It is intended for use by a healthcare solution integrator to build web, mobile or another types of applications to let qualified healthcare professionals review and confirm the analytic result. The product supports downloading and analyzing data recorded in the compatible formats from dedicated ambulatory ECG devices such as Holter, event recorder, Outpatient Cardiac Telemetry devices or other similar recorders when the assessment of the rhythm is necessary. The product can be electronically interfaced and perform analysis with data transferred from other computer-based ECG systems, such as an ECG management system. DeepRhythmAI | HeartKey Rhythm is intended for use by qualified health-care professionals for analyzing ECG data from adults. HeartKey Rhythm analyzes a single ECG lead recorded from compatible devices used for arrhythmia diagnostics such as Holters, Extended Holters, ECG Patches, Event Recorders, or other similar devices when assessment of the rhythm is necessary. The HeartKey Rhythm application program interface (API) is intended to be integrated into other device software to provide the following capabilities: • ECG signal conditioning, • ECG signal quality assessment, • QRS beat detection, • Ventricular ectopic beat detection, • ECG rhythm analysis HeartKey Rhythm is not intended for use in life supporting, or sustaining systems, or real-time ECG | Vista Solution 2.1 is a software user interface intended for use by healthcare professionals to display physiological data collected by the VitalConnect Platform wireless remote monitoring system in home and healthcare settings. Vista Solution is a secondary, adjunct patient monitor and is not intended to replace existing standard-of-care patient monitoring practices. The VitalConnect Platform is a wireless remote monitoring system intended for use by healthcare professionals for continuous collection of physiological data in home and healthcare settings. This can include heart rate, electrocardiography (ECG), heart rate variability, R-R interval, respiratory rate, body temperature, skin temperature, activity (including step count), and posture (body position relative to gravity including fall). Data are transmitted wirelessly from the VitalConnect Sensor for storage and analysis. The VitalConnect Platform can include the ability to notify healthcare professionals when physiological data fall outside selected parameters. The device is intended for use on general care patients who are 18 years of age or older as a general patient monitor, to provide physiological information. The | The VitalConnect Platform is a wireless remote monitoring system intended for use by healthcare professionals for continuous collection of physiological data in home and healthcare settings. This can include heart rate, electrocardiography (ECG), heart rate variability, R-R interval, respiratory rate, body temperature, skin temperature, activity (including step count), and posture (body position relative to gravity including fall). Data are transmitted wirelessly from the VitalConnect Sensor for storage and analysis. The VitalConnect Platform can include the ability to notify healthcare professionals when physiological data fall outside selected parameters. The device is intended for use on general care patients who are 18 years of age or older as a general patient monitor, to provide physiological information. The |
Page 9
| | life-supporting or sustaining systems or for critical care monitoring. The arrhythmia analysis results are not intended to be the sole means of diagnosis and are offered on an advisory basis only, in conjunction with the physician's knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information. | can be integrated into medical devices. In this case, the medical device manufacturer will identify the indication for use depending on the application of their device. DeepRhythmAI is not for use in life-supporting or sustaining systems or ECG Alarm devices. Interpretation results are not intended to be the sole means of diagnosis. It is offered to physicians and clinicians on an advisory basis only in conjunction with the physician's knowledge of ECG patterns, patient background, clinical history, symptoms and other diagnostic information. | monitors, or cardiac alarm devices, or OTC-use only devices. HeartKey Rhythm analysis results are not intended to be the sole means of diagnosis. It is offered to physicians and clinicians on an advisory basis only in conjunction with the physician's knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information. | data from the VitalConnect Platform are intended for use by healthcare professionals as an aid to diagnosis and treatment. VitalPatch device can be used on patients with pacemakers that comply with ISO 14117:2012 and ANSI/AAMI PC69:2000 without deviations. Heart rate, electrocardiography (ECG), heart rate variability, R-R interval, and respiratory rate are not intended for patients with pacemakers. The device is not intended for use on critical care patients. |
| Intended Use | Continuous and automatic analysis of arrhythmias from ECG data and RR interval for use in outpatient cardiac telemetry and patient monitoring in non-critical healthcare settings for non-urgent clinical decision-making | Continuous and automatic analysis of ECG data in adult patients for use in outpatient cardiac telemetry, Holter, event recorder or other similar devices | Continuous and automatic analysis of beats and arrhythmias from ECG data for use in non-active patient monitoring or for non-urgent clinical decision making | Vista Solution Platform is a wireless remote monitoring system intended for display of physiological data and triggering notifications. | The VitalPatch biosensor is intended for the continuous collection of physiological data in home and healthcare settings. |
| Cardiac Arrhythmia Detection | • Atrial fibrillation/atrial flutter • AV Block (2nd degree, Type I and II) • Pause • Paroxysmal supraventricular tachycardia (PSVT) • Ventricular tachycardia/run • Sinus bradycardia • Sinus tachycardia • Normal sinus rhythm • Others (inconclusive) | • Atrial Fibrillation detection • Non-paced arrhythmias interpretation • Non-paced ventricular arrhythmia calls • Cardiac Pause • Tachycardia • Bradycardia • Inconclusive • Unreadable | • Atrial fibrillation • Normal sinus rhythm • Cardiac Pause • Tachycardia • Bradycardia • Inconclusive • Unreadable | Vista Solution does not detect cardiac arrhythmias; however, it can display physiological data collected by the VitalConnect platform | Not Applicable |
Page 10
| Beat detection | VitalRhythm does not detect beats, however, beat detection such as QRS detection, RR interval, Heart Rate and Heart Rate Variability are provided by the VitalPatch reference device | • QRS detection • Heart rate determination for non-paced adult • Ventricular ectopic beats detection • Supraventricular ectopic beats detection • R-R interval detection | • Beat Clustering - Beat cluster template - Beat cluster count - QRS location - Beat classification • Heart Rate • Beat Analysis - Normal (N) - Ventricular (V) ectopic | Vista Solution does not detect beats, however, it displays beat detection features such as QRS detection, RR interval, Heart Rate and Heart Rate Variability are provided by the VitalPatch reference device | • QRS detection • RR interval • Heart Rate • Heart Rate Variability |
| Patient Population | Patients who are 18 years of age or older | Adults | Adults over the age of 18 | Patients who are 18 years of age or older | Patients who are 18 years of age or older |
| 510(k) Number | K242129 | K241197 | K233755 | K193343 | K192757 |
| Device Classification | Class II | Class II | Class II | Class II | Class II |
| Classification Product Codes | DQK, DPS, QYX | DQK, DPS, QYX | DQK, DPS | DRG | DRG, DSI, MHX |
| Classification Names | Programmable Diagnostic Computer, Electrocardiograph, Outpatient Cardiac Telemetry | Programmable Diagnostic Computer, Electrocardiograph, Outpatient Cardiac Telemetry | Programmable Diagnostic Computer, Electrocardiograph | | |
| Regulation Numbers | 870.1425 870.2340 870.1025 | 870.1425 870.2340 870.1025 | 870.1425 870.2340 | 870.2910 | 870.2910 870.1025 |
Page 11
| • Non-paced arrhythmias interpretation • Non-paced ventricular arrhythmia calls | • Cardiac Pause • Tachycardia • Bradycardia • Inconclusive • Unreadable | arrhythmias; however, it can display physiological data collected by the VitalConnect platform | |
|---|---|---|---|
| Beat detection | VitalRhythm does not detect beats, however, beat detection such as QRS detection, RR interval, Heart Rate and Heart Rate Variability are provided by the VitalPatch reference device | • QRS detection • Heart rate determination for non-paced adult • Ventricular ectopic beats detection • Supraventricular ectopic beats detection • R-R interval detection | • Beat Clustering - Beat cluster template - Beat cluster count - QRS location - Beat classification • Heart Rate • Beat Analysis - Normal (N) - Ventricular (V) ectopic |
| Patient Population | Patients who are 18 years of age or older | Adults | Adults over the age of 18 |
| 510(k) Number | K242129 | K241197 | K233755 |
| Device Classification | Class II | Class II | Class II |
| Classification Product Codes | DQK, DPS, QYX | DQK, DPS, QYX | DQK, DPS |
| Classification Names | Programmable Diagnostic Computer, Electrocardiograph, Outpatient Cardiac Telemetry | Programmable Diagnostic Computer, Electrocardiograph, Outpatient Cardiac Telemetry | Programmable Diagnostic Computer, Electrocardiograph |
| Regulation Numbers | 870.1425 870.2340 870.1025 | 870.1425 870.2340 870.1025 | 870.1425 870.2340 |
| Use Environment | Home or non-critical healthcare settings | Unknown | Hospital or home |
| Components | Software only (SaMD): 1) A web API 2) A cloud-based, automated proprietary ECG interpretation support algorithm | Software only (SaMD): 1) A web API 2) An automated proprietary algorithm | Software only (SaMD): 1) A web API 2) An automated proprietary algorithm |
| Programming Interface | Web application programming interface (API) | Web application programming interface (API) | Web application programming interface (API) |
| Part responsible for ECG signal arrhythmia analysis | The automated proprietary algorithm developed using deep-learning techniques, which measures and analyzes ECG data to provide certified cardiac technicians and qualified healthcare professionals the ability to review and confirm the analytic result | The automated proprietary deep-learning algorithm, which measures and analyzes ECG data to provide qualified healthcare professional with supportive information for review. | The automated proprietary machine-learning algorithm, which measures and analyzes ECG data to provide qualified healthcare professional with supportive information for review |
| Number of leads for a received ECG signal | Single-lead ECG data with sampling frequency of 125 Hz and dynamic range of -10 mV to +10mV | Two-lead ECG data | A single lead ECG data |
| Display or Graphical User Interface (GUI) | No primary display or GUI | No primary display or GUI | No primary display or GUI |
Page 12
| qualified healthcare professionals. | |
|---|---|
| Fundamental Scientific Technology | The VitalRhythm application: • accepts ECG and RR-interval data from the VitalPatch device via secure API (Application Programming Interface). • analyzes the data using a proprietary algorithm, which detects specified cardiac arrhythmias. • arrhythmias detected by the software algorithm are returned with interpretation results to be reviewed by a qualified healthcare professional. |
| Continuous Analysis of ECG signals | YES |
Indications for Use Comparison
The VitalRhythm, DeepRhythmAI and HeartKey Rhythm devices are intended for continuous analysis of ECG signals for arrhythmia detection. The indications of the VitalRhythm subject device are similar, but not identical, to the cleared predicate device.
The VitalRhythm subject device, DeepRhythmAI predicate device and HeartKey Rhythm reference device are indicated for analyzing ECG signals and providing the analytical results to healthcare professionals as supportive information. Like the DeepRhythmAI predicate device and HeartKey Rhythm reference device, the VitalRhythm device is not intended to be used with patients requiring life-supporting or life-sustaining systems and the arrhythmia analyses are not intended to be the sole means of diagnosis. Both the VitalRhythm subject device and DeepRhythmAI predicate device continuously and automatically analyze ECG signals for outpatient cardiac telemetry. Both the VitalRhythm subject device and HeartKey Rhythm reference device continuously and automatically analyze ECG signals in either the home or non-critical healthcare settings for non-urgent clinical decision-making.
While the VitalRhythm subject device is compatible with only the VitalConnect reference devices (VitalPatch biosensor and Vista Solution), the DeepRhythmAI and HeartKey Rhythm devices can be integrated into other devices. While the VitalRhythm subject device detects only arrhythmias, the DeepRhythmAI and HeartKey Rhythm devices detect both arrhythmias and beats (QRS detection and ectopic beats). However, beat detection features such as QRS detection, RR interval, Heart Rate and Heart Rate Variability are provided by the compatible, previously cleared VitalConnect reference devices (VitalPatch biosensor and Vista Solution). These differences do not result in a new intended use for VitalRhythm as compared to its predicate devices.
Technological Comparison
The VitalRhythm device's technological characteristics are similar to those of the cleared predicate device.
The VitalRhythm device, DeepRhythmAI device and HeartKey Rhythm device are stand-alone software applications that are compatible with other devices. The VitalRhythm device, DeepRhythmAI device and HeartKey Rhythm device accept continuous ECG signal data (as opposed to retrospective data) from the compatible devices for analysis. The
Page 13
VitalRhythm device, DeepRhythmAI device and HeartKey Rhythm device use proprietary algorithms based on machine-learning techniques to analyze the ECG signals. VitalRhythm detects cardiac rhythms that are similar to those detected by the DeepRhythmAI predicate device and HeartKey Rhythm reference device.
Both VitalRhythm and the HeartKey Rhythm reference device analyze single-lead ECG data while the DeepRhythmAI predicate device analyzes two-lead ECG data. While the VitalRhythm subject device is compatible with only the VitalConnect reference devices (VitalPatch biosensor and Vista Solution), the DeepRhythmAI predicate device and HeartKey Rhythm reference device can be integrated into other compatible devices. Unlike the DeepRhythmAI predicate device and HeartKey Rhythm reference device, the VitalRhythm subject device does not detect beats; however, beat detection features such as QRS detection, RR interval, Heart Rate and Heart Rate Variability are provided by the compatible, previously cleared VitalConnect reference devices (VitalPatch biosensor and Vista Solution).
In conclusion, the technological differences between VitalRhythm, when used with compatible VitalConnect reference devices, and the DeepRhythmAI predicate device, do not raise new questions of safety or effectiveness. Therefore, the VitalRhythm subject device is substantially equivalent to the predicate device.
VII. Non-Clinical and/or Clinical Tests Summary & Conclusions
Nonclinical testing included de-identified ECG and RR-interval data obtained retrospectively from patients prescribed the VitalPatch biosensor across clinical sites in the United States (US).
The training database was from 354 US clinical sites, and consists of 23,587 patients and 81,391 datasets. The independent test database contains VitalPatch data from 3,309 patients (18 years of age or older) across 7 US testing sites and consists of 7,553 datasets with a total of 22,034 annotated arrhythmia episodes indicating a wide sampling of arrhythmias to support a robust generalization of the algorithm. To ensure an unbiased performance assessment, test datasets are sequestered at the clinical site level.
The performance of VitalRhythm, when assessed using the independent test database, in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy is provided in the table below:
Page 14
| Rhythm | Sample size | Observed performance |
|---|---|---|
| Patient | Dataset | |
| Atrial fibrillation/ flutter | 421 | 1512 |
| AV block (2nd degree, Type I and II) | 118 | 716 |
| Paroxysmal supraventricular tachycardia | 689 | 1003 |
| Ventricular tachycardia/run | 610 | 737 |
| Pause | 200 | 960 |
| Others (inconclusive) | 1547 | 1923 |
| Sinus | 3009 | 5906 |
| Normal sinus rhythm | 2394 | 4201 |
| Sinus bradycardia | 488 | 1009 |
| Sinus tachycardia | 914 | 1161 |
Subgroup analyses performed to evaluate potential heterogeneity (Mann Whitney Wilcoxon test, p ≥ 0.01) in the detection performance of the VitalRhythm algorithm across demographic factors (patients' age, gender, race, ethnicity and body mass index), dataset durations, and testing sites did not result in statistically significant differences.
The test results demonstrated that performance of the VitalRhythm algorithm, when assessed on the independent test database, in terms of sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), and accuracy met the acceptance criteria of ≥ 95% for non-sinus rhythms including Atrial fibrillation/ flutter, AV block (2nd degree, Type I and II), Paroxysmal supraventricular tachycardia, Ventricular tachycardia/run, Pause and Others (Inconclusive). Additionally, the test results showed that sinus rhythms including Normal sinus rhythm, Sinus bradycardia and Sinus tachycardia met the acceptance criteria of ≥ 90% with regard to sensitivity, specificity, PPV, NPV, and accuracy.
No additional clinical testing was required to support this submission.
Substantial Equivalence Conclusion
The nonclinical performance data collected in support of the proposed indication demonstrate that use of VitalRhythm is as safe and as effective and performs as well as or better than the predicate devices to detect target arrhythmias. The scientifically valid performance data establish substantial equivalence and demonstrate that the differences between VitalRhythm and its predicate do not raise different questions of safety and effectiveness.